Clinical trials
Phase 1 Obesity trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 5 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 6 |
| Unity Health Toronto | 2 |
| University of Alberta | 2 |
| University of Guelph | 2 |
| 35Pharma Inc | 1 |
| Alnylam Pharmaceuticals | 1 |
| BaroSense Inc. | 1 |
| NuBiyota | 1 |
| University of Calgary | 1 |
| University of Manitoba | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 21 |
| Overweight | 5 |
| Diabetes Mellitus | 4 |
| Cardiovascular Diseases | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Hyperlipidemias | 2 |
| Hypertension | 2 |
| Insulin Resistance | 2 |
| Lipid Metabolism Disorders | 2 |
| Metabolic Syndrome | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.